About Cytel
Cytel is a Healthcare company based in Cambridge (United States) founded in 1987 by Cyrus Mehta and Nitin Patel, and was acquired by Nordic Capital in December 2020. Data analysis and statistical solutions are provided for life sciences. Cytel has raised $2 million across 8 funding rounds from investors including Merck, HHS and New Mountain Capital. Cytel has completed 5 acquisitions, including MTEK Sciences, Purple Squirrel and SDS Life Science. Its chief executive, as recorded, is Jovan Willford. Its website cytel.com draws about 28 thousand monthly visits. Its Indian entity Cytel Statistical Software & Services Pr Ivate Limited reported revenue of ₹168 Cr. Cytel offers products and services including Trial Design Software, Axio Data Monitoring, and LiveSLR Software. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Charles River Laboratories, DNAnexus and LabCorp; 1 of its 3 listed competitors has raised funding.
Company details
Cytel was founded in 1987 and is headquartered in Cambridge, United States. Statistical solutions and data analytics are offered for the life sciences sector, focusing on clinical trial design, analysis, and real-world evidence generation. Software tools and services are supplied to support drug development processes, including regulatory submissions. Operations emphasize insights for pharmaceutical and biotech applications across global markets.
- Headquarters Cambridge, United States
- Founders Cyrus Mehta, Nitin Patel
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cytel.com
- Social LinkedIn X Facebook
- Acquired by Nordic Capital (Dec 2020)
- Legal Name Cytel Statistical Software & Services Pr Ivate Limited
- Date of Incorporation 03 Apr, 2001
- Jurisdiction Pune, Maharashtra, India
- Indian entity revenue₹168 Cr
FY 2025 · +8% YoY
- Indian entity net profit₹23.60 Cr
FY 2025 · 14% margin
- Indian entity EBITDA₹32.69 Cr
FY 2025 · 19% margin
- Total Equity Funding$2M (USD)
in 8 rounds
- InvestorsMerck
& 5 more
- Investments & AcquisitionsMTEK Sciences
& 4 more
- Acquired byNordic Capital
(Dec 2020)
Associated legal entities of Cytel
Cytel operates through Cytel Statistical Software & Services Pr Ivate Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cytel Statistical Software & Services Pr Ivate Limited CIN U72200PN2001PTC016025 | Active | 03 Apr 2001 | Pune, Maharashtra | ₹168 Cr | 509 | 3 | View details |
Products & Services of Cytel
Cytel offers a comprehensive portfolio of products and services, including Trial Design Software, Axio Data Monitoring, and LiveSLR Software.
Enables simulation and optimization of clinical trial protocols.
Facilitates monitoring and analysis of clinical trial data.
Supports systematic literature reviews for research insights.
Funding Insights of Cytel
Cytel has successfully raised a total of $2M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 8
- Investors Count 4
All 8 funding rounds of Cytel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | Series A | – | – | ||
| May 2015 | $99,562 | Grant | – | – | |
| Jun 2010 | $184,521 | Grant | – | – | |
| Jun 2010 | $1.11M | Grant | – | – | |
| Jul 2009 | $1.04M | Grant | – | – | |
| Jun 2009 | $106,212 | Grant | – | – | |
| Feb 2005 | $2M | Series A | – | – | |
| Apr 1994 | Grant | – | – |
6 investors in total: 6 institutional.
Investors in Cytel
Cytel has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, HHS and New Mountain Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
New Mountain Capital manages investments in private equity, credit, and net lease strategies. | newmountaincapital.com | |||
| sbir.nih.gov | ||||
| nordiccapital.com | ||||
Astorg is engaged in private equity investment management. | astorg.com | Paris, France | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | merck.com | Kenilworth, United Kingdom |
Investor details for Cytel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cytel Statistical Software & Services Pr Ivate Limited (Cytel)
Cytel Statistical Software & Services Pr Ivate Limited is the primary company behind Cytel. The board of Cytel Statistical Software & Services Pr Ivate Limited currently have 3 directors; the longest-serving is Anagha Ajitkumar Chaphalkar, appointed in 2021. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anagha Ajitkumar Chaphalkar DIN 06505536 | Director | 25 Mar 2021 | 5 yrs 6 mo | Cytel Statistical Software & Services Pr Ivate Limited |
| Santosh Sundar Shetty DIN 09738238 | Director | 30 Sep 2022 | 4 yrs | Cytel Statistical Software & Services Pr Ivate Limited |
| Aniruddha Sudhakar Deshmukh DIN 10045969 | Director | 06 Mar 2023 | 3 yrs 7 mo | Cytel Statistical Software & Services Pr Ivate Limited |
People of Cytel
383 people are tracked at Cytel (115 in leadership, 268 in team).
| Name | Role | Group |
|---|---|---|
Cyrus Mehta | Co-Founder & President | Leadership |
| Co-Founder | Leadership | |
Jovan Willford | CEO | Leadership |
Shashank Maratkar | Associate Director - Software Engineerning | Leadership |
Swathi M. | Associate Director | Leadership |
Stephanie Gautier | Associate Director Biostatistics | Leadership |
Edgar .. | Associate Director Clinical Data Management | Leadership |
Virginie Jego | Director, Biostatistician | Leadership |
Jennifer Sustin | Associate Director, Clinical Data Management | Leadership |
W. Greg Latouf | Sr. Director, Business Intelligence & Resource Management | Leadership |
Kevin Thornton | Associate Director, Clinical Data Management | Leadership |
Yi-Ting Tsai | Associate Director Biostatistics | Leadership |
Valeria Mazzanti | Associate Director, Customer Success | Leadership |
Kimberly K. | Associate Director Of Biostatistics | Leadership |
Sharada Harricharan | Senior Director & Research Principal | Leadership |
Evie Merinopoulou | Senior Director, Real World Evidence | Leadership |
Ben Rousseau | Vice President, Market Access (value Communication And HTA Submission) | Leadership |
Catherine Ressayre | Associate Director Biostatistics | Leadership |
Jeanne Corriveau | Senior Director, Statistical Programming | Leadership |
Shanna Cotti-Osmanski | Chief Digital And Information Officer | Leadership |
363 more people are available in the full profile.
Complete people profiles for Cytel
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cytel
Figures of Cytel Statistical Software & Services Pr Ivate Limited, the primary company behind Cytel, for FY 2025. Revenue was ₹168 Cr (+8% year on year). Net profit was ₹23.60 Cr (14% margin). EBITDA was ₹32.69 Cr (19% margin). Revenue has grown at a compounded annual rate of +8% over three years and +10% over five years.
- ₹168 CrRevenue · FY 2025 · +8% YoY
- ₹23.60 CrNet profit · 14% margin
- ₹32.69 CrEBITDA · 19% margin
- ₹3.1 LakhPaid-up capital
- 509Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cytel Statistical Software & Services Pr Ivate Limited are on its company page.
Detailed financial statements for Cytel
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytel
Cytel has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include MTEK Sciences, Purple Squirrel and SDS Life Science.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Healthcare solutions are provided for pharmaceutical and medical technology sectors. | cofaktor.de | Berlin, Germany | 0 | Oct 2023 | •••• | |
Provider of project management and quality assurance services for medical devices manufacturers | sdsmedteq.com | Danderyd, Sweden | 2020 | Oct 2022 | •••• | |
Provider of drug development, regulatory affairs, biostatistics, and clinical project management services | sdslifescience.com | Stockholm, Sweden | 2012 | Oct 2022 | •••• | |
Provider of market access services to biopharma sector | purplesquirreleconomics.com | New York, United States | 2016 | Dec 2020 | •••• | |
Software is developed for clinical study design and analysis. | mteksciences.com | Vancouver, Canada | 2017 | Nov 2019 | •••• |
Complete acquisition details for Cytel
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cytel
9 dated milestones of Cytel across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Cytel is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
- Acquisition Acquires MTEK Sciences.
- Acquisition Acquires Purple Squirrel.
- Exit Acquired by Nordic Capital.
- Acquisition Acquires SDSMedteQ.
- Acquisition Acquires SDS Life Science.
- Acquisition Acquires co.faktor.
Competitors of Cytel
Cytel has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, DNAnexus and LabCorp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | 21,400 | Provider of drug discovery and preclinical development services | ||
| dnanexus.com | 2009 | Mountain View, United States | $472.55M | 143 | Cloud-based genome informatics and data management are provided. | |
| labcorp.com | 1969 | Burlington, United States | 9,321 | Provider of laboratory tests for physicians |
Detailed competitors of Cytel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cytel
The website of Cytel (cytel.com) receives about 28.2K visits a month.
- Monthly visits28.2K
▲ 23.5% vs previous month
Websites whose visitors overlap most with Cytel. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| amstat.org | 100% | 189.4K | #214,722 | View details | |
| statistics.com | 92% | 24.4K | #1,186,643 | View details | |
jmp.com | jmp.com | 84% | #88,056 | – | |
| minitab.com | 79% | #68,164 | View details | ||
| westat.com | 77% | 174.7K | #209,554 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Cytel
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cytel (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytel
Complete news archive for Cytel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytel
Cytel was founded in 1987 and raised its 1st funding round 7 years after it was founded.
Cytel is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Jovan Willford is the CEO of Cytel, as recorded in our data.
Cytel is a funded company, having raised a total of $2M across 8 funding rounds to date.
The primary company behind Cytel, Cytel Statistical Software & Services Pr Ivate Limited, reported revenue of ₹168 Cr for FY 2025, up 8% year on year.
Cytel was founded in 1987 and is headquartered in Cambridge, United States. Statistical solutions and data analytics are offered for the life sciences sector, focusing on clinical trial design, analysis, and real-world evidence generation. Software tools and services are supplied to support drug development processes, including regulatory submissions. Operations emphasize insights for pharmaceutical and biotech applications across global markets.
Cytel's top competitors include DNAnexus, LabCorp and Charles River Laboratories.
Cytel offers Trial Design Software, Axio Data Monitoring, and LiveSLR Software.
Cytel has made 5 acquisitions, including MTEK Sciences, Purple Squirrel, and SDS Life Science.
Cytel has 6 investors. Key investors include Merck, HHS, New Mountain Capital, NIH SBIR/STTR, and Nordic Capital.
Cytel operates through Cytel Statistical Software & Services Pr Ivate Limited.
Yes. Cytel was acquired by Nordic Capital in December 2020.